Binding of a venom Lys-49 phospholipase A2 to LPS and suppression of its effects on mouse macrophages

Toxicon

Volumn 50, Issue 7, 2007, Pages 914-922

  Tsai, Shu Huei ^a   Chen, Yen Chou ^b   Chen, Linda ^a   Wang, Ying Ming ^c   Tsai, Inn Ho ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

Anti septic agent; Lipopolysacharide binding protein; Lys49 phospholipase A2 homolog; Macrophage; Microcalorimetry titration

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHOSPHOLIPASE A2; RANTES; SNAKE VENOM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME REPRESSION; MACROPHAGE; MICROCALORIMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SNAKE;

ANIMALS; CELL LINE; CHEMOKINE CCL2; CHEMOKINE CCL5; DOWN-REGULATION; GENE EXPRESSION REGULATION; GROUP II PHOSPHOLIPASES A2; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN ISOFORMS; REPTILIAN PROTEINS;

CROTALINAE; VIRIDOVIPERA STEJNEGERI;

EID: 35649005384     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.06.025     Document Type: Article

References (41)

1. Augusto L.A., Decottignies P., Synguelakis M., Nicaise M., Le Marechal P., and Chaby R. Histones: a novel class of lipopolysaccharide-binding molecules. Biochemistry 42 (2003) 3929-3938
2. Baldwin A.S. Control of oncogenesis and cancer-therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107 (2001) 241-246
3. Cerami A., and Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 9 (1988) 28-31
4. 2 from Brothropes asper snake venom: pharmacological mediation and molecular determinants. Toxicon 41 (2003) 667-678
5. 2 (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide. Pain 108 (2004) 180-191
6. Dam J., and Schuck P. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol. 384 (2004) 185-212
7. 2. J. Biol. Chem. 269 (1994) 13057-13060
8. Greene H.W., May P.G., Hardy D.L., Sciturro J.M., and Farrell T.M. Parental behavior by vipers. In: Schuett G.W., Hoggren M., Douglas M.E., and Greene H.W. (Eds). Biology of the Vipers (2002), Eagle Mountain Publishing, USA 179-205
9. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 344 (1994) 721-725
10. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner B.M., Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., and Peyron J. Tyrosine phosphorlation of IκB-α activates NFκB without proteolytic degradation of IκB-α. Cell 86 (1996) 787-798
11. Koul D., Yao Y., Abbruzzese J.L., Yung W.K., and Reddy S.A. Tumor suppressor MMAC/PTEN inhibits cytokine induced NF-κB activation without interfering with the IκB degradation pathway. J. Biol. Chem. 276 (2001) 11402-11408
12. 2 against Staphylococcus aureus. J. Immunol. 162 (1999) 7402-7408
13. 2 to Escherichia coli infection. Infect. Immun. 68 (2000) 87-92
14. 2 homologues: dissociation between enzymatic and biological activities. Eur. J. Pharmacol. 343 (1998) 257-263
15. Lehmann V., Freudenberg M.A., and Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J. Exp. Med. 165 (1987) 657-663
16. Li Y., Wang X., and Wang Y. Comparative studies on interactions of bovine serum albumin with cationic gemini and single-chain surfactants. J. Phys. Chem. B 110 (2006) 8499-8505
17. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42 (2003) 885-901
18. Luster A.D. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
19. 2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. Toxicon 45 (2005) 651-660
20. Morrison D.C., and Ryan J.L. Endotoxins and disease mechanisms. Annu. Rev. Med. 38 (1987) 417-432
21. 2 homologues. Toxicon 49 (2007) 378-387
22. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994) 253-264
23. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II (115-129)-peptide identifies its bactericidal region. Eur. J. Biochem. 153 (1998) 452-461
24. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., and Nabel G.J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275 (1997) 523-527
25. Richmond A. NF-κB, chemokine gene transcription and tumor growth. Nat. Rev. Immunol. 2 (2002) 664-674
26. Rietschel E.T., Brade H., Holst O., Brade L., Müller-Loennies S., Mamat U., Zähringer U., Beckmann F., Seydel U., Brandenberg K., Ulmer A.J., Mattern T., Heine H., Schletter J., Schönbeck U., Flad H.-D., and Hauschildt S. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immuol. 216 (1996) 39-81
27. 2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon 45 (2005) 807-815
28. Schuck P., Perugini M.A., Gonzalez N.R., Howlett G.J., and Schubert D. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys. J. 82 (2002) 1096-1111
29. Shletter J., Heine H., Ulmer A.J., and Rietschel E.T. Molecular mechanisms of nedotoxin activity. Arch. Microbiol. 164 (1995) 383-389
30. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
31. Srimal S., Surolia N., Balasubramanian S., and Surolia A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem. J. 315 (1996) 679-686
32. 2. Toxicon 42 (2003) 947-962
33. 2 of Asian snake venoms. J. Toxicol. Toxin Rev. 16 (1997) 79-114
34. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
35. 2 and disintegrins of Protobothrops pit vipers. Biochim. Biophys. Acta Prot. Proteome 1702 (2004) 111-119
36. 2 of bamboo viper (Trimeresurus stejnegeri): molecular characterization, geographic variations and evidence of multiple ancestries. Biochem. J. 377 (2004) 215-223
37. Voss S., Welte S., Fotin-Mleczek M., Fischer R., Ulmer A.J., Jung G., Wiesmuller K.H., and Brock R. A CD14 domain with lipopolysaccharide-binding and -neutralizing activity. Chembiochem 7 (2006) 275-286
38. Xie Q.-W., Washiwabara Y., and Nathan C. Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269 (1994) 4705-4708
39. Zhong H., Voll R.E., and Ghosh S. Rearranged NF-κB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Mol. Cell 1 (1998) 661-671
40. 2 isolated from Bothrops asper snake venom: role of catalytic activity. Toxicon 45 (2005) 335-346
41. 2. Toxicon 46 (2005) 523-532